Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Biomedical and Environmental Sciences ; (12): 314-320, 2005.
Article in English | WPRIM | ID: wpr-229749

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effect of alpha-zearalenol on angiotensin II-induced beta3 integrin mRNA expression in human umbilical vein endothelial cells (HUVECs).</p><p><b>METHODS</b>The mRNA level in integrin beta3 was determined by reverse transcription-polymerase chain reaction. Endothelial NF-kappaB activity was determined by the luciferase activity assay of plasmid NF-kappaB-LUC.</p><p><b>RESULTS</b>The angiotensin II-induced beta3 integrin mRNA expression was inhibited by alpha-zearalenol and 17beta-estradiol (10 nmol/L -1 micromol/L), but not influenced by ICI 182, 780, a pure competitive antagonist for estrogen receptor or a nitric oxide inhibitor Nomega-Nitro-L-arginine methyl ester hydrochloride. Alpha-zearalenol and 17beta-estradiol suppressed the angiotensin II-induced activation of NF-kappaB in endothelial cells.</p><p><b>CONCLUSION</b>Alpha-zearalenol inhibits angiotensin II-induced integrin beta3 mRNA expression by suppressing NF-kappaB activation in endothelial cells.</p>


Subject(s)
Female , Humans , Angiotensin II , Cells, Cultured , Endothelial Cells , Metabolism , Endothelium, Vascular , Metabolism , Estradiol , Pharmacology , Gene Expression Regulation , Integrin beta3 , Genetics , NF-kappa B , Physiology , Nitric Oxide , Phytoestrogens , Pharmacology , RNA, Messenger , Metabolism , Receptors, Estrogen , Zeranol , Pharmacology
2.
Chinese Journal of Medical Genetics ; (6): 14-18, 2004.
Article in Chinese | WPRIM | ID: wpr-329409

ABSTRACT

<p><b>OBJECTIVE</b>To identify the mutation of low density lipoprotein receptor(LDLR) gene in a large Chinese family with familial hypercholesterolemia(F H) and make a discussion on the pathogenesis of FH at the molecular level.</p><p><b>METHODS</b>Investigations were made on a patient with the clinical phenotype of homozygous FH and his parents for mutations of promoter and all 18 exons of LDLR gene. Screening was carried out using Touch down PCR and a g arose gel electrophoresis, combined with DNA sequence analysis. The results were compared with the normal sequences in GenBank and FH database (www.ucl.uk/fh) t o find the mutation. Then the mutation was identified in other members of the family. In addition, the authors screened the apolipoprotein B(100) (apoB(100)) gene f or known mutations (R3500Q) that cause familial defective apoB(100) (FDB) by PCR-RFLP.</p><p><b>RESULTS</b>A novel homozygous IN III 5' GT --> AT mutation in the splice donor of LDLR intron 3 was detected in the homozygote propositus with FH. The mutation was also identified in four heterozygous carriers in his family. No mutations R3500Q of apoB(100)were observed.</p><p><b>CONCLUSION</b>A homozygous G --> A splice mutation in LDLR gene was first reported. The change of the splice donor in LDLR intron 3 may cause skipping of exon 3, which is responsible for FH. Perhaps it is a particular pathogenesis for Chinese people.</p>


Subject(s)
Adolescent , Adult , Child , Female , Humans , Male , Middle Aged , Alternative Splicing , Genetics , Base Sequence , China , DNA , Chemistry , Genetics , DNA Mutational Analysis , Homozygote , Hyperlipoproteinemia Type II , Blood , Genetics , Pathology , Lipids , Blood , Mutation , Pedigree , Point Mutation , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Receptors, LDL , Genetics
SELECTION OF CITATIONS
SEARCH DETAIL